Stock RNXT RENOVORX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus RenovoRx, Inc.

Equities

RNXT

US75989R1077

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.243 USD +2.73% Intraday chart for RenovoRx, Inc. +6.24% -45.72%
Apr. 16 RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting CI
Apr. 15 RenovoRx, Inc. announced that it has received $11.136652 million in funding CI

Evolution of the average Target Price on RenovoRx, Inc.

Price target over the last 5 years

History of analyst recommendation changes

1fb6174f6a104da0949.Mn2lLGguQjMEgBBlQ-z0a-mNunm_Db3viUE1ZVSyNhE.ZC_IH1xadHdszk8AcoG6P6G_wDz4XNq-0whbNTDgYFd3Rf1dMHYMQ0LKJA~c1bc9f04cd170be85112cdceaa915b81

Analyst Recommendations on RenovoRx, Inc.

Alliance Global Starts RenovoRx With Buy Rating, $4 Price Target MT
Maxim Downgrades RenovoRx to Hold From Buy MT
Roth MKM Adjusts Price Target on RenovoRx to $13 From $14, Maintains Buy Rating MT
Roth Capital Starts RenovoRx at Buy With $16 Price Target MT
RENOVORX : Maxim Starts RenovoRx at Buy with $15 Price Target MT
RenovoRx : Files for IPO, Sets Target Price of $11-$13/Unit MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.243 USD
Average target price
3.75 USD
Spread / Average Target
+201.69%
High Price Target
4 USD
Spread / Highest target
+221.80%
Low Price Target
3.5 USD
Spread / Lowest Target
+181.58%

Consensus detail

Consensus revision (last 18 months)

Analysts covering RenovoRx, Inc.

Alliance Global Partners
Maxim
Roth MKM
Roth Capital Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RNXT Stock
  4. Consensus RenovoRx, Inc.